Danaher Corporation launched a collaboration with Johns Hopkins University aiming to develop new methods for diagnosing mild TBI. As part of the Danaher Beacons program, researchers at Johns Hopkins University will leverage technology from Beckman Coulter Diagnostics, a Danaher subsidiary and leader in clinical diagnostics, to potentially establish correlations between a new biomarker panel and clinical outcomes.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
265.8 USD | +0.33% | +4.90% | +14.90% |
May. 17 | Danaher Insider Sold Shares Worth $2,386,325, According to a Recent SEC Filing | MT |
May. 15 | Danaher Insider Sold Shares Worth $4,866,675, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.90% | 197B | |
+12.15% | 227B | |
+18.22% | 141B | |
+29.15% | 110B | |
+1.52% | 64.15B | |
+16.92% | 53.72B | |
+6.33% | 51.75B | |
+10.93% | 45.2B | |
+5.87% | 37.37B | |
+27.06% | 32.11B |
- Stock Market
- Equities
- DHR Stock
- News Danaher Corporation
- Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis